STE vs VTRS — Key Metrics

Metric STE (STERIS PLC) VTRS (VIATRIS INC)
Price259.5720.28
Market Cap25.21 Billion23.25 Billion
P/E (TTM)30.68-38.26
P/B (Quarterly)3.41.589
P/S (TTM)4.091.58
Net Profit Margin (TTM)13.4-4.1
Gross Margin (TTM)44.635.3
ROE (TTM)11.5-4.2
Revenue Growth YoY (TTM)n/an/a

Upfront Investment - S&P 500 Stock Comparison & AI Analysis

AI-powered analysis and comparison tools for S&P 500 stocks, helping investors make data-driven decisions with delayed market data and portfolio modeling.

STERIS PLC
vs
 
VIATRIS INC
 
STERIS PLC
vs
 
VIATRIS INC
Performance Comparison
AI Model Recommendation
STE · STERIS PLC

Greatly Underperform

-92
UnderperformOutperform
VTRS · VIATRIS INC

Greatly Outperform

67
UnderperformOutperform
Recommendation Summary

Stock STE is projected to greatly underperform the market, stock VTRS is projected to greatly outperform the market. Upfront Recommendation: VTRS.

Financial Metrics
Prices delayed ~15 min
STE Metrics VTRS
$259.57 Price $20.28
— Market Capitalization —
4.09 Price to Sales 1.58
26.6 Price to FCF Ratio 10.85
9.17 Price to Gross Profit 4.47
212.89 Price to R&D 23.17
10.17 Price to Current Assets 2.26

STE vs VTRS at a glance

Steris PLC (STE) and Viatris INC (VTRS) are both in the Healthcare sector. They are similar in size: $25.2 billion and $23.3 billion in market value.

On trailing-twelve-month figures, STE trades at 4.1 times trailing sales and VTRS at 1.6; net profit margins are 13.4% and -4.1%.

The Upfront Investment model currently rates STE Greatly Underperform and VTRS Greatly Outperform as of November 18, 2026. The rating ranks the model's medium-term return forecast against the other stocks it scores; it is a statistical forecast, not investment advice.